fda compounding semaglutide enforcement november 2025 Compounded weight loss drugs get new life as Eli Lilly, Novo Nordisk push back The GLP-1 drug boom has

Tirzepatide's dual GIP/GLP-1 mechanism makes it distinct from pure GLP-1 agonists like semaglutide or liraglutide

The point is that they appear to be systemic metabolic therapies with effects that reach beyond simple appetite suppression

Zepbound and Mounjaro are not compounded and are registered trademarks of Eli Lilly

Hopefully I can be with BMH forever because you guys really do a great job

The patients who received the GLP-1 infusion had a significant improvement in left ventricular ejection fraction, VO2 max, and 6-minute walking distance

The combination of excellent glucose control, substantial weight loss, cardiovascular protection, and kidney benefits makes these medications the clear first choice for many patients